| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.4 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | 0.045 | 0.4 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.4 |
| mRNA | Vorinostat | FIMM | pan-cancer | AAC | 0.14 | 0.4 |